Intervention

SIPPS and Being a Reader Small-Group Reading Meet the Requirements of the Virginia Literacy Act

Retrieved on: 
星期二, 四月 30, 2024
Supplement, Intervention, SIPPS, Reader, School, Thought, Literacy, Curriculum, Science, Student, Growth, Tutoring

Both programs meet the requirements of the Virginia Literacy Act and appear on Virginia's Recommended Instruction Program Guide.

Key Points: 
  • Both programs meet the requirements of the Virginia Literacy Act and appear on Virginia's Recommended Instruction Program Guide.
  • Approved under Supplemental, the Being a Reader Small-Group Reading Sets program for grades K–2 is designed to supplement any whole-class reading curriculum.
  • For schools using Being a Reader Small-Group Reading Sets to supplement core instruction, SIPPS provides an aligned Tier II or Tier III intervention.
  • "Additionally, they have committed to providing science of reading professional development opportunities, contributing to the growth of highly skilled reading educators across Virginia."

Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com

Retrieved on: 
星期二, 四月 23, 2024
Health, Clinical Trials, USD, FDA, Phase, Cancer, Pain management, SARS-CoV-2, Food, Viral, Intervention, Personalized medicine, Blockchain, Machine learning, Diabetes, National Cancer Institute, Research, Vaccine, ChromeOS, Therapy, Incidence, Patient, NCI, Clinical trial, Expanded access, Prevalence, Pharmaceutical industry

The global clinical trials market is split into phases: Phase 1, Phase 2, Phase 3, and Phase 4.

Key Points: 
  • The global clinical trials market is split into phases: Phase 1, Phase 2, Phase 3, and Phase 4.
  • By indication, the global clinical trials market is categorized into Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others.
  • By study material, the global clinical trials market is fragmented into Interventional, Observational, and Expanded Access.
  • The requirement for clinical trials to improve diagnostic tests and vaccines for viral illnesses such as SARS-CoV-2 has exponentially augmented the demand for clinical trials.

Happy Anniversary, IXL Learning: Celebrating 25 Years of Innovation

Retrieved on: 
星期二, 四月 23, 2024
Education, Intervention, Language, Textbook, Ecosystem, Learning, San Francisco International Airport, Enrichment, Heart, Literacy, Student, Growth, Richardson Independent School District, Teachers Pay Teachers, Dictionary.com, Reference.com, Science, Rosetta Stone, Acquisition, TPT, Organization, SAN, K-12, Tutoring

SAN MATEO, Calif., April 23, 2024 /PRNewswire/ -- IXL Learning proudly commemorates its 25th anniversary this year and celebrates its mission to redefine possibilities in education. Since its inception, the company has been a force for change, pushing boundaries to shape a brighter future for educators and learners everywhere.

Key Points: 
  • Fueled by the belief that innovation would be crucial for solving future challenges in education, Paul Mishkin began coding in his apartment, laying the foundation for what would become IXL Learning.
  • In 2001, IXL Learning capitalized on its success in digitizing education by launching Quia Books, an interactive textbook and workbook platform complete with an intelligent grading system.
  • At the time, IXL Learning was a modest operation based in an unheated warehouse next to San Francisco International Airport.
  • "IXL Learning has spent the past 25 years evolving, innovating, and most importantly, cultivating a distinct vision that has helped us disrupt the status quo," says Paul Mishkin, Founder & CEO of IXL Learning.

Gallaudet University Awarded $3.75 Million to Create a National Implementation and Change Center for the Early Hearing Detection and Intervention Program

Retrieved on: 
星期二, 四月 16, 2024
MCHB, Education, American Academy, Intervention, HHS, Early, Hearing, Hands & Voices, Communication, Unitary state, Gallaudet University, Pediatrics (journal), Acquisition, National Network, HRSA, Mother, Government, Nursing

WASHINGTON, April 16, 2024 /PRNewswire/ -- Gallaudet University announced today that it has entered into a five-year, $3.75 million cooperative agreement with the Maternal and Child Health Bureau ( MCHB ) in the Health Resources and Services Administration ( HRSA ) to establish the new Implementation and Change Center within the Early Hearing Detection and Intervention (EHDI) National Network.

Key Points: 
  • WASHINGTON, April 16, 2024 /PRNewswire/ -- Gallaudet University announced today that it has entered into a five-year, $3.75 million cooperative agreement with the Maternal and Child Health Bureau ( MCHB ) in the Health Resources and Services Administration ( HRSA ) to establish the new Implementation and Change Center within the Early Hearing Detection and Intervention (EHDI) National Network.
  • Gallaudet University joins esteemed partners including Hands & Voices, serving as the Family Leadership in Language and Learning Center, and the American Academy of Pediatrics, serving as the Provider Education Center, in this collective effort.
  • The National Beacon Center will support EHDI programs throughout the United States, as well as the nation's system of services for deaf and hard of hearing children.
  • To learn more about Gallaudet University, please visit https://gallaudet.edu/ .

A-GAME Announces Appointment of Thomas Bond, MD, MS as Chief Medical Officer

Retrieved on: 
星期四, 三月 21, 2024
Doctor of Medicine, Health, Longevity, Bond, Drink, Intervention, Nutrition, Regenerative medicine, Physician, Education, Patient, Family medicine, University, Athlete, Exercise, Biophysics, Carolinas Medical Center, Sports medicine, Major League Baseball, LSU, Dentistry

ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.

Key Points: 
  • ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.
  • Bond will act as the first Chief Medical Officer for A-GAME Beverages and bring years and valuable experience of both clinical and sideline expertise in the field of Sports Medicine.
  • Dr.
  • Bond was recruited to LSU Medical Center in New Orleans as the Chief of Sports Medicine.

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results

Retrieved on: 
星期四, 三月 28, 2024
Medical Devices, FDA, Health, Health Technology, Clinical Trials, Biotechnology, U.S. FDA, Intervention, Patient, Research, Table, Bank statement, Clinical trial, Society, GAAP, Marketing

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2023.
  • “In 2023 the Pulse Biosciences team executed on the development of our portfolio of CellFX nsPFA devices.
  • Non-GAAP costs and expenses for the full year of 2023 were $35.1 million compared to $51.3 million in the prior year.
  • Cash used in the fourth quarter of 2023 was $6.9 million compared to $8.0 million in the same period in the prior year and $8.7 million used in the third quarter of 2023.

Safer Schools, Better Behaviour Campaign: CPI's Essential Breaking Up Fights™ Training Offers Immediate Solution for Staff to Address Spike in Violence in School

Retrieved on: 
星期二, 三月 26, 2024
School, Intervention, CPI, Aggression, Risk, CPD, Student, Panic, Injury, Ambiguity, The central science, Training, Safety, Nursing

MANCHESTER, England, March 26, 2024 /PRNewswire/ -- Recent surveys from CPI (Crisis Prevention Institute)[1] and TeacherTapp[2] reveal that a third of teachers witness a fight among pupils on a weekly basis, a 55% increase in the last 2 years.  While 96% of teachers feel obligated to intervene, mindful of their duty of care toward pupils, yet 74% feel unclear on intervention guidance within school settings. This leaves teachers ill-prepared to address physical altercations among students.

Key Points: 
  • While 96% of teachers feel obligated to intervene, mindful of their duty of care toward pupils, yet 74% feel unclear on intervention guidance within school settings.
  • In response to this pressing need, CPI has launched a training solution tailored specifically for school staff.
  • Breaking Up Fights™: Intervention Skills training equips staff with essential strategies to maximise safety and minimise harm.
  • With a 97% satisfaction rate, Breaking Up Fights™ Training has already proven its effectiveness in addressing the critical challenges faced by school staff.

MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders

Retrieved on: 
星期一, 三月 11, 2024
Psilocybin, SAN, Mental health, County, MAPS, Quality, Education, FDA, City, Intervention, Curriculum, Risk, Safety, Health, Medicine, Knowledge, LPC, Law enforcement, Psychiatry, Public, Nursing

MAPS uses its over 30 years of experience in the psychedelic space to offer a gold-standard training program.

Key Points: 
  • MAPS uses its over 30 years of experience in the psychedelic space to offer a gold-standard training program.
  • MAPS looks to share this training with other interested jurisdictions.
  • SAN JOSE, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) has partnered with the City and County of Denver to provide comprehensive training on psychedelic crisis assessment and intervention to the city’s first responders.
  • MAPS’ training aims to enhance the knowledge, attitudes, and skills of first responders to quickly recognize and effectively respond to emotional and behavioral crisis incidents involving psilocybin and other psychedelics.

Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

Retrieved on: 
星期五, 三月 8, 2024
Research, General Health, Technology, Medical Devices, Other Manufacturing, Health Technology, Clinical Trials, Science, Biotechnology, Wearables, Mobile Technology, Health, Diabetes, Manufacturing, TIR, Dexcom, CGM, Doctor of Philosophy, Randomized controlled trial, MD, Treatment, Medical director, G6, AID, Intervention, Conference, ATTD, Safety, Hypoglycemia, Control, RCT, T1D, Corporation, DKA, Body mass index, Treatment and control groups, Pharmaceutical industry

The OP5-003 Trial results were presented at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy.

Key Points: 
  • The OP5-003 Trial results were presented at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy.
  • "Omnipod 5 continues to demonstrate impressive clinical outcomes for people with type 1 diabetes,” said Professor Renard.
  • The control group (n=62) continued to use their usual insulin pump with a Dexcom G6 CGM, while the intervention group (n=132) used Omnipod 5 with Dexcom G6.
  • In conclusion, this multi-national, RCT data demonstrates the superiority of the Omnipod 5 AID System compared to standard pump therapy with CGM and indicates that it should be offered as a first-line therapy for adults with type 1 diabetes.

Expro Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
星期三, 二月 21, 2024
Alternative Energy, Energy, Other Energy, Oil, Gas, Well, Depreciation, MENA, Fashion show, Intervention, Continental shelf, Tax, PRT, Segment, GAAP, LWI, Central Time, Integrity, Partnership, TRS, Carbon, Safety, Public expenditure, Kingdom, Acquisition, ESSA, Risk, NLA

Net cash provided by operating activities for the fourth quarter of 2023 was $33 million compared to net cash provided by operating activities of $59 million for the third quarter of 2023.

Key Points: 
  • Net cash provided by operating activities for the fourth quarter of 2023 was $33 million compared to net cash provided by operating activities of $59 million for the third quarter of 2023.
  • Adjusted cash flow from operations1 for the fourth quarter of 2023 was $43 million compared to $64 million for the third quarter of 2023.
  • Unless otherwise noted, the following discussion compares the quarterly results for the fourth quarter of 2023 to the results for the third quarter of 2023.
  • Depreciation and amortization expense was $63 million for the fourth quarter of 2023 compared to $37 million for the third quarter of 2023.